Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from VSTECS Holdings Limited ( (HK:0856) ) is now available.
VSTECS Holdings Limited has clarified additional details in its 2024 annual report regarding 4,540,000 shares repurchased during the year and held as treasury shares for potential resale or to satisfy future share grants, and it confirmed that its 2015 share option scheme had roughly six months of life remaining at year-end 2024 with no options then granted, exercised, cancelled, lapsed or outstanding, leaving 152,542,799 options available for grant under the scheme. In its 2025 interim reporting, the company disclosed that during the first half of 2025 it granted 29,400,000 share options to all directors and 65 full‑time employees, tied to ambitious revenue growth targets for a specified subsidiary over 2025–2027, and noted that the scheme has since expired with no options remaining available for grant, underscoring a strategic use of equity incentives to drive performance ahead of the scheme’s expiry while maintaining previously reported financial information unchanged.
The most recent analyst rating on (HK:0856) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on VSTECS Holdings Limited stock, see the HK:0856 Stock Forecast page.
More about VSTECS Holdings Limited
VSTECS Holdings Limited, together with its subsidiaries, operates in the information technology sector, focusing on distribution and related services across its markets. The group utilises equity incentive tools such as share option and share award schemes to align directors and employees with the company’s long‑term performance and shareholder interests.
Average Trading Volume: 7,237,150
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.03B
For a thorough assessment of 0856 stock, go to TipRanks’ Stock Analysis page.

